P3 Health Partners

P3 Health Partners ROE

The Return on Equity (ROE) of P3 Health Partners (PIII) as of Oct 23, 2026 is 95.31 %. In the previous year, Return on Equity (ROE) was -178.90 % — a change of -153.27% (higher).

ROE

95.31 %

YoY

-153.27%

Last updated:

In 2025, P3 Health Partners's return on equity (ROE) was 95.31 %, a -153.27% increase from the -178.90 % ROE in the previous year.

The P3 Health Partners ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
99.81 USD
Jan 1, 2020
24.12 USD
Jan 1, 2022
-4,614.40 USD
Jan 1, 2023
-40.65 USD
Jan 1, 2024
-178.90 USD
Jan 1, 2025
95.31 USD
The P3 Health Partners ROE history
YEARROEYoY
95.31 %-153.27%
-178.90 %+340.12%
-40.65 %-99.12%
-4,614.40 %-19,229.17%
24.12 %-75.83%
99.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

P3 Health Partners Stock analysis

What does P3 Health Partners do? P3 Health Partners, Inc. generates revenue by providing professional support services to doctors and clinicians through its P3 care model. The company supports approximately 2,800 affiliated primary care providers across Arizona, Nevada, Florida, Oregon, California, and other states, offering value-based care coordination and administrative services that enhance patient outcomes while reducing costs. Its services include education, tools, and support for illness management, prevention, wellness, medication management, nursing assistance, access to community resources, and care transition teams. The firm serves healthcare providers who seek to improve patient experiences and operational efficiency within the population health management sector. The company's primary customers are primary care providers who partner with P3 Health Partners to implement its value-based care model. These providers benefit from the firm’s administrative support and care coordination services, which help them navigate the healthcare system and improve patient care. P3 Health Partners focuses on expanding its network of affiliated providers to deliver comprehensive care management solutions across multiple states, leveraging its established presence in Arizona, Nevada, Florida, Oregon, and California to scale its services. P3 Health Partners operates within the population health care management industry, targeting providers who require support in transitioning to value-based care models. The company’s revenue streams are derived from the services it provides to its network of primary care providers, including care coordination, administrative support, and wellness programs. By enhancing the patient experience through integrated care management, the firm helps its partners achieve better health outcomes and cost efficiencies, positioning itself as a key player in the evolving healthcare landscape. P3 Health Partners is one of the most popular companies on Eulerpool.

ROE Details

Decoding P3 Health Partners's Return on Equity (ROE)

P3 Health Partners's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing P3 Health Partners's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

P3 Health Partners's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in P3 Health Partners’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about P3 Health Partners stock

Return on Equity (ROE) of P3 Health Partners is 95.31 % in 2025.

Return on Equity (ROE) of P3 Health Partners changed from -178.90 % to 95.31 %, representing a -153.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) P3 Health Partners since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s P3 Health Partners with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — P3 Health Partners

All Key Metrics — P3 Health Partners